Bedoradrine-d6
CAS: 194785-19-8
Ref. 3D-UHA78519
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Información del producto
- Acetamide, N,N-dimethyl-2-[[(7S)-5,6,7,8-tetrahydro-7-[[(2R)-2-hydroxy-2-[4-hydroxy-3-(2-hydroxyethyl)phenyl]ethyl]amino]-2-naphthalenyl]oxy]-
- Acetamide, N,N-dimethyl-2-[[5,6,7,8-tetrahydro-7-[[2-hydroxy-2-[4-hydroxy-3-(2-hydroxyethyl)phenyl]ethyl]amino]-2-naphthalenyl]oxy]-, [R-(R*,S*)]-
- N,N-Dimethyl-2-[[(7S)-5,6,7,8-tetrahydro-7-[[(2R)-2-hydroxy-2-[4-hydroxy-3-(2-hydroxyethyl)phenyl]ethyl]amino]-2-naphthalenyl]oxy]acetamide
Bedoradrine-d6 is an analog of bedoradrine that acts as a potent inhibitor of kinases. It has been shown to inhibit the activity of cyclin-dependent kinases, which play a critical role in the regulation of cell division and proliferation. Bedoradrine-d6 has demonstrated promising anticancer effects in cancer cells, inducing apoptosis and inhibiting tumor growth. This protein kinase inhibitor has been extensively studied in Chinese hamster ovary cells and human cancer cell lines, showing significant medicinal potential for cancer treatment. As a kinase inhibitor, bedoradrine-d6 represents a promising therapeutic option for cancer patients who require targeted therapy to combat their disease.
Propiedades químicas
Consulta técnica sobre: 3D-UHA78519 Bedoradrine-d6
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
